NorstellaLinQ: Complex Cohort Identification Fuels Real-Time HCP Targeting
MMIT’s NorstellaLinQ integrates structured and unstructured real-world data (RWD) to help oncology manufacturers identify complex cohorts in real time. By combining diagnostic codes, lab results, and NLP-driven clinical note analysis, pharma companies can reach prescribing physicians earlier in the treatment journey.
Download the Use Case
Advanced Patient Identification
Use diagnostic codes, lab results, and unstructured EMR data to surface hard-to-find patients.
Cohort Segmentation
Stratify patients by disease progression, tumor grading, and other clinical factors.
Physician Targeting at Scale
Deliver timely insights to prescribing physicians through weekly, customized data pulls.